Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$14,104
+$357 QoQ
Shares Held
90
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,517
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aventus Investment Advisors, Inc. holds $206,048 across 5 Drug Manufacturers - General names. NVS ranks #4 (6.8% of the industry book) .
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,104 | 90 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $13,747 | 90 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $12,408 | 90 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $11,541 | 90 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $10,890 | 90 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||